Inflammadry
Payments companies reported to CMS as associated with Inflammadry. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Inflammadry, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Inflammadry
These are the largest totals companies reported as associated with Inflammadry. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Paul Olivo | Saint Louis, MO | Internal Medicine | $6,495.00 |
| John Sistrunk | Jackson, MS | Endocrinology, Diabetes & Metabolism | $2,400.00 |
| Kendall Donaldson | Miami, FL | Ophthalmology | $123.42 |
| Victor Perez Quinones | Durham, NC | Cornea and External Diseases Specialist | $123.42 |
| Alfonso Sabater | Miami, FL | Cornea and External Diseases Specialist | $123.42 |
| Beeran Meghpara | Philadelphia, PA | Ophthalmology | $122.54 |
| Thomas Kislan | Stroudsburg, PA | Optometrist | $119.64 |
| Michael Kay | Philadelphia, PA | Ophthalmology | $109.88 |
| Kristin Didomenico | Philadelphia, PA | Ophthalmology | $109.88 |
| Steven Reto | West Chester, PA | Optometrist | $101.11 |
Prescribed Inflammadry?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.